Syringe Supplier-Buyer Network — Trade Flow Analysis

Name: Syringe Supplier-Buyer Trade Network Dataset — 291+ Indian Exporters, 21+ Importers, 154+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Syringe supplier network, Syringe buyers, pharmaceutical export India, Syringe trade data

TransData Nexus

Syringe

India Pharmaceutical Trade Intelligence

$179.9M291 Suppliers154 CountriesHS 30049099

ExportsIndia → UNITED STATES36.7%India → BELGIUM14.1%

#1 Buyer: FRESENIUS KABI

Who Supplies Syringe? Top Manufacturers & Buyers 2026 — GLAND PHARMA LTD Leads | TransData Nexus | TransData Nexus

1GLAND PHARMA LTD

GLAND PHARMA LTD is the first-largest Syringe exporter from India, with a market share of 31.0% and a total export value of $55.8M across 619 shipments. Their average shipment value of $90.1K is above the market average of $51.1K, suggesting premium or bulk contract pricing.

GLAND PHARMA LTD serves 5 named buyers in our database. FRESENIUS KABI USA LLC is the dominant customer, accounting for 63.8% of this supplier's tracked business. Top customers include:

• FRESENIUS KABI USA LLC — $35.6M across 395 shipments (63.8% of this supplier's total exports)

• BOSTON ONCOLOGY ARABIA — $8.5M across 94 shipments (15.2% of this supplier's total exports)

• EVERSANA — $5.7M across 63 shipments (10.2% of this supplier's total exports)

• EVERSANA LIFE SCIENCE SERVICES LLC — $4.8M across 53 shipments (8.6% of this supplier's total exports)

• NORDIC PHARMACEUTICAL CO SAC — $1.2M across 13 shipments (2.2% of this supplier's total exports)

Key Insight: GLAND PHARMA LTD's per-shipment value of $90.1K is 76% above the market average of $51.1K, consistent with large-order contracts or value-added formulations.

2GLAND PHARMA LIMITED

GLAND PHARMA LIMITED is the second-largest Syringe exporter from India, with a market share of 14.7% and a total export value of $26.4M across 234 shipments. Their average shipment value of $113.0K is above the market average of $51.1K, suggesting premium or bulk contract pricing.

GLAND PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• FRESENIUS KABI USA LLC — $11.8M across 104 shipments (44.6% of this supplier's total exports)

• BOSTON ONCOLOGY ARABIA — $7.5M across 67 shipments (28.5% of this supplier's total exports)

• EVERSANA EVERSANA — $3.6M across 32 shipments (13.7% of this supplier's total exports)

• STATE PHARMACEUTICALS CORPORATION — $2.0M across 18 shipments (7.5% of this supplier's total exports)

• EVERSANA — $1.5M across 13 shipments (5.7% of this supplier's total exports)

Key Insight: GLAND PHARMA LIMITED's per-shipment value of $113.0K is 121% above the market average of $51.1K, consistent with large-order contracts or value-added formulations.

3INDIAN IMMUNOLOGICALS LIMITED

INDIAN IMMUNOLOGICALS LIMITED is the third-largest Syringe exporter from India, with a market share of 13.2% and a total export value of $23.7M across 158 shipments. Their average shipment value of $149.8K is above the market average of $51.1K, suggesting premium or bulk contract pricing.

INDIAN IMMUNOLOGICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• CENTURION ILAC SANAYI VE TICARET — $8.7M across 58 shipments (36.6% of this supplier's total exports)

• 2 WORLD TRADERS INC — $8.0M across 53 shipments (33.8% of this supplier's total exports)

• DUC MINH MEDICAL JOINT STOCK COMPAN — $4.4M across 29 shipments (18.5% of this supplier's total exports)

• CENTURION ILAC SANAYI VE TICARET — $1.9M across 13 shipments (7.9% of this supplier's total exports)

• DUC MINH MEDIACL JOI — $728.7K across 5 shipments (3.1% of this supplier's total exports)

Key Insight: INDIAN IMMUNOLOGICALS LIMITED's per-shipment value of $149.8K is 193% above the market average of $51.1K, consistent with large-order contracts or value-added formulations.

4SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fourth-largest Syringe exporter from India, with a market share of 12.2% and a total export value of $21.9M across 99 shipments. Their average shipment value of $221.5K is above the market average of $51.1K, suggesting premium or bulk contract pricing.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. YUSEN LOGISTICS BENELUX BELGIUM is the dominant customer, accounting for 94.8% of this supplier's tracked business. Top customers include:

• YUSEN LOGISTICS BENELUX BELGIUM — $20.8M across 94 shipments (94.8% of this supplier's total exports)

• DOUGLAS PHARMACEUTIC — $460.1K across 2 shipments (2.1% of this supplier's total exports)

• YUSEN LOGISTICS BENELUX BELGIUM — $307.3K across 1 shipments (1.4% of this supplier's total exports)

• SUN PHARMA ANZ PTY L — $204.7K across 1 shipments (0.9% of this supplier's total exports)

• M/S. DOUGLAS PHARMAC — $178.2K across 1 shipments (0.8% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $221.5K is 334% above the market average of $51.1K, consistent with large-order contracts or value-added formulations.

5MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the fifth-largest Syringe exporter from India, with a market share of 2.8% and a total export value of $5.0M across 13 shipments. Their average shipment value of $388.4K is above the market average of $51.1K, suggesting premium or bulk contract pricing.

MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. COMMERCIAL BANK OF ETHIOPIA, is the dominant customer, accounting for 95.9% of this supplier's tracked business. Top customers include:

• COMMERCIAL BANK OF ETHIOPIA, — $4.8M across 12 shipments (95.9% of this supplier's total exports)

• COMMERCIAL BANK OF ETHIOPIA, — $99.0K across 0 shipments (2.0% of this supplier's total exports)

• UNITED NATIONS POPUL — $68.4K across 0 shipments (1.4% of this supplier's total exports)

• UNFPA RWANDA — $41.1K across 0 shipments (0.8% of this supplier's total exports)

• MR COLUM FRASER — $4 across 0 shipments (0.0% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $388.4K is 660% above the market average of $51.1K, consistent with large-order contracts or value-added formulations.

6JODAS EXPOIM PRIVATE LIMITED

JODAS EXPOIM PRIVATE LIMITED is the fifth-largest Syringe exporter from India, with a market share of 1.9% and a total export value of $3.4M across 20 shipments. Their average shipment value of $170.3K is above the market average of $51.1K, suggesting premium or bulk contract pricing.

JODAS EXPOIM PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• OOOJODAS EXPOIM — $1.5M across 9 shipments (43.6% of this supplier's total exports)

• OOOJODAS EXPOIM — $718.0K across 4 shipments (21.1% of this supplier's total exports)

• SOFTCARE INTERNATION — $634.1K across 4 shipments (18.6% of this supplier's total exports)

• OOOJODAS EXPOIM — $461.1K across 3 shipments (13.5% of this supplier's total exports)

• SOFTCARE INTERNATION — $107.0K across 1 shipments (3.1% of this supplier's total exports)

Key Insight: JODAS EXPOIM PRIVATE LIMITED's per-shipment value of $170.3K is 234% above the market average of $51.1K, consistent with large-order contracts or value-added formulations.

1United States

United States ranks as the first-largest destination for Syringe imports from India, with a total trade value of $66.1M across 530 shipments — representing a 36.7% share of all Syringe exports. The average shipment value of $124.7K is above the global average of $51.1K, indicating high-value procurement contracts or branded formulations. This market is served by 6 tracked buyers.

Named Syringe importers in United States: FRESENIUS KABI USA, LLC is the largest buyer, accounting for 53.8% ($35.6M) of this market's total imports.

• FRESENIUS KABI USA, LLC — $35.6M (53.8% of United States's total)

• FRESENIUS KABI USA LLC — $12.0M (18.1% of United States's total)

• EVERSANA — $7.2M (10.9% of United States's total)

Key Insight: United States's per-shipment average of $124.7K (144% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Syringe imports from India.

Primary Market

Secondary Market

2Belgium

Belgium ranks as the second-largest destination for Syringe imports from India, with a total trade value of $25.4M across 95 shipments — representing a 14.1% share of all Syringe exports. The average shipment value of $267.3K is above the global average of $51.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Syringe importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 98.8% ($25.1M) of this market's total imports.

• YUSEN LOGISTICS BENELUX BELGIUM — $25.1M (98.8% of Belgium's total)

Key Insight: Belgium's per-shipment average of $267.3K (423% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Belgium is a key market for Syringe imports from India.

Primary Market

Secondary Market

3Saudi Arabia

Saudi Arabia ranks as the third-largest destination for Syringe imports from India, with a total trade value of $16.1M across 95 shipments — representing a 8.9% share of all Syringe exports. The average shipment value of $169.0K is above the global average of $51.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Syringe importers in Saudi Arabia: BOSTON ONCOLOGY ARABIA is the largest buyer, accounting for 99.6% ($16.0M) of this market's total imports.

• BOSTON ONCOLOGY ARABIA — $16.0M (99.6% of Saudi Arabia's total)

Key Insight: Saudi Arabia's per-shipment average of $169.0K (231% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Saudi Arabia is a key market for Syringe imports from India.

Primary Market

Secondary Market

4Philippines

Philippines ranks as the fourth-largest destination for Syringe imports from India, with a total trade value of $11.2M across 24 shipments — representing a 6.2% share of all Syringe exports. The average shipment value of $468.0K is above the global average of $51.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Syringe importers in Philippines: 2 WORLD TRADERS INC is the largest buyer, accounting for 78.3% ($8.8M) of this market's total imports.

• 2 WORLD TRADERS INC — $8.8M (78.3% of Philippines's total)

Key Insight: Philippines's per-shipment average of $468.0K (816% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Philippines is a key market for Syringe imports from India.

Primary Market

Secondary Market

5Turkey

Turkey ranks as the fifth-largest destination for Syringe imports from India, with a total trade value of $10.8M across 38 shipments — representing a 6.0% share of all Syringe exports. The average shipment value of $283.0K is above the global average of $51.1K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Syringe importers in Turkey: CENTURION ILAC SANAYI VE TICARET AN is the largest buyer, accounting for 80.6% ($8.7M) of this market's total imports.

• CENTURION ILAC SANAYI VE TICARET AN — $8.7M (80.6% of Turkey's total)

• CENTURION ILAC SANAYI VE TICARET — $1.9M (17.4% of Turkey's total)

Key Insight: Turkey's per-shipment average of $283.0K (454% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Turkey is a key market for Syringe imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Syringe.
2.Flow Mapping: 291 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,522 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 154 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

3,522 Verified Shipments

291 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Syringe

Syringe

Who Supplies Syringe? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Syringe? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Syringe Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1GLAND PHARMA LTD

2GLAND PHARMA LIMITED

3INDIAN IMMUNOLOGICALS LIMITED

4SUN PHARMACEUTICAL INDUSTRIES LIMITED

5MYLAN LABORATORIES LIMITED

6JODAS EXPOIM PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Syringe Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Syringe Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Belgium

3Saudi Arabia

4Philippines

5Turkey

People Also Ask — Syringe Supplier & Trade Network

Syringe Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology